Jacobi Capital Management LLC - AIMMUNE THERAPEUTICS INC ownership

AIMMUNE THERAPEUTICS INC's ticker is AIMT and the CUSIP is 00900T107. A total of 152 filers reported holding AIMMUNE THERAPEUTICS INC in Q3 2019. The put-call ratio across all filers is 1.27 and the average weighting 0.5%.

Quarter-by-quarter ownership
Jacobi Capital Management LLC ownership history of AIMMUNE THERAPEUTICS INC
ValueSharesWeighting
Q3 2020$7,000
+133.3%
2000.0%0.00%0.0%
Q2 2020$3,0000.0%2000.0%0.00%0.0%
Q1 2020$3,000
-57.1%
2000.0%0.00%0.0%
Q4 2019$7,000
+75.0%
2000.0%0.00%0.0%
Q3 2019$4,0002000.00%
Other shareholders

There were no reported owners of AIMMUNE THERAPEUTICS INC in Q3 2019.

NameSharesValueWeighting ↓
View complete list of AIMMUNE THERAPEUTICS INC shareholders